2023 European Society of Cardiology guidelines for the management of acute coronary syndromes: Statement of endorsement by the NVVC
Publication date
2024-10
Authors
Zwart, Bastiaan
Claessen, Bimmer E.P.M.
Damman, Peter
Woudstra, Pier
Vink, Maarten A.
Balder, Jan-Willem
Dickinson, Michael G
Badings, Erik A.
Appelman, Yolande
van ’t Hof, Arnoud W.J.
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
This review discusses the new recommendations in the 2023 European Society of Cardiology guidelines on the management of acute coronary syndrome and provides a perspective on topics specific to clinical practice in the Netherlands, including pre-treatment, antiplatelet agent strategies, the use of risk scores and logistical considerations with regard to the timing of coronary angiography.
Keywords
Acute coronary syndrome, Antiplatelet therapy, Guidelines, Percutaneous coronary intervention, Cardiology and Cardiovascular Medicine
Citation
Zwart, B, Claessen, B E P M, Damman, P, Woudstra, P, Vink, M A, Balder, J W, Dickinson, M G, Badings, E A, Appelman, Y, van ’t Hof, A W J, ten Berg, J M & Arslan, F 2024, '2023 European Society of Cardiology guidelines for the management of acute coronary syndromes : Statement of endorsement by the NVVC', Netherlands Heart Journal, vol. 32, no. 10, pp. 338-345. https://doi.org/10.1007/s12471-024-01896-2